Keith Westby

854 total citations · 2 hit papers
6 papers, 632 citations indexed

About

Keith Westby is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Keith Westby has authored 6 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Ophthalmology, 3 papers in Molecular Biology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Keith Westby's work include Retinal Diseases and Treatments (4 papers), Retinal and Optic Conditions (2 papers) and Retinal Imaging and Analysis (2 papers). Keith Westby is often cited by papers focused on Retinal Diseases and Treatments (4 papers), Retinal and Optic Conditions (2 papers) and Retinal Imaging and Analysis (2 papers). Keith Westby collaborates with scholars based in United States, Italy and United Kingdom. Keith Westby's co-authors include Glenn J. Jaffe, Harvey Masonson, Joel Pearlman, Jordi Monés, Sunil Patel, Brian C. Joondeph, Karl G. Csaky, Kourous A. Rezaei, John Randolph and Thomas A. Ciulla and has published in prestigious journals such as Endocrinology, Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Keith Westby

6 papers receiving 613 citations

Hit Papers

C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Du... 2020 2026 2022 2024 2020 2023 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Westby United States 5 461 303 258 63 36 6 632
Harvey Masonson United States 6 497 1.1× 324 1.1× 248 1.0× 53 0.8× 36 1.0× 6 654
Georg Mossböck Austria 14 393 0.9× 193 0.6× 105 0.4× 27 0.4× 44 1.2× 29 477
Yumiko Saishin United States 10 440 1.0× 254 0.8× 336 1.3× 30 0.5× 30 0.8× 10 639
Katharina E. Schmid‐Kubista Austria 10 330 0.7× 292 1.0× 173 0.7× 104 1.7× 35 1.0× 15 542
Angela J. Cree United Kingdom 16 565 1.2× 324 1.1× 243 0.9× 149 2.4× 35 1.0× 35 711
J. Fant United States 8 237 0.5× 207 0.7× 263 1.0× 30 0.5× 50 1.4× 10 511
Anand Rajendran India 11 406 0.9× 221 0.7× 164 0.6× 37 0.6× 9 0.3× 25 552
Yeo Sia Wey Singapore 7 288 0.6× 197 0.7× 207 0.8× 48 0.8× 10 0.3× 11 429
Jennyfer Zerbib France 16 609 1.3× 315 1.0× 310 1.2× 142 2.3× 44 1.2× 23 747
Annette M. Aoki United States 9 226 0.5× 270 0.9× 229 0.9× 39 0.6× 119 3.3× 10 559

Countries citing papers authored by Keith Westby

Since Specialization
Citations

This map shows the geographic impact of Keith Westby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Westby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Westby more than expected).

Fields of papers citing papers by Keith Westby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Westby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Westby. The network helps show where Keith Westby may publish in the future.

Co-authorship network of co-authors of Keith Westby

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Westby. A scholar is included among the top collaborators of Keith Westby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Westby. Keith Westby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Patel, Sunil, David R. Lally, Jason Hsu, et al.. (2023). Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye. 37(17). 3551–3557. 82 indexed citations breakdown →
2.
Csaky, Karl G., Keith Westby, & Kourous A. Rezaei. (2020). Avacincaptad Pegol, A Novel C5 Inhibitor, Significantly Reduces the Mean Rate of Geographic Atrophy Growth in a Pivotal Clinical Trial. Investigative Ophthalmology & Visual Science. 61(7). 1943–1943. 1 indexed citations
3.
Jaffe, Glenn J., Keith Westby, Karl G. Csaky, et al.. (2020). C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration. Ophthalmology. 128(4). 576–586. 307 indexed citations breakdown →
4.
Ciulla, Thomas A., et al.. (2018). Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States. Ophthalmology Retina. 2(7). 645–653. 83 indexed citations
5.
Jaffe, Glenn J., Thomas A. Ciulla, Antonio P. Ciardella, et al.. (2016). Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration. Ophthalmology. 124(2). 224–234. 114 indexed citations
6.
Perry, Mark, Keith Westby, Nathan Brown, et al.. (2003). Luteinizing Hormone Receptor Knockout (LuRKO) Mice and Transgenic Human Chorionic Gonadotropin (hCG)-Overexpressing Mice (hCG αβ+) Have Bone Phenotypes. Endocrinology. 144(8). 3555–3564. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026